Published by Michele Maatouk on 19th August 2026
(Sharecast News) - Pharmaceutlcal firms Moderna and MSD (Merck Sharp & Dohme (UK) Limited) said on on Wednesday that a personalised mRNA melanoma vaccine they are jointly developing had shown positive results in a first-ever late-stage trial.
URL: http://www.digitallook.com/dl/news/story/36151275/...